EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments. Cancer’s complex nature requires integration of advanced research data across national boundaries to enable progress. The Horizon Europe mission board for cancer has identified access to data, knowledge, and digital services – accessible across the European Research Area through federated infrastructures – as a key enabling condition for success. The better we organise cancer data across Europe, the better and faster we can bring the fruits of new biological and technical innovations to the benefit of EU citizens/patients. EOSC4Cancer’s well curated data sets will be essential input for reproducible and robust analytics and computational methods – including machine learning and artificial intelligence. EOSC4Cancer’s five use cases will cover the patient journey from cancer prevention over diagnosis to treatment, laying the foundation of data trajectories and workflows for future European Cancer Mission projects. EOSC4Cancer brings together a consortium of 29 organisations from 13 countries, including cancer research centres, research infrastructures, leading research groups, hospitals, and supercomputing centres. To make the developments sustainable, EOSC4Cancer will leverage the partners’ research infrastructures partners and the EOSC ecosystem. It will also serve the European Cancer Mission, by engaging with large international coalitions (e.g., ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action) and patients/survivors associations.
Network detailsCatalogueASK-Tx
Asklepios Biobank für Lungenerkrankungen - Asklepios Biobank for Lung Diseases
Description
Es ist das Ziel der Biobank, Gewebe, Blut und andere Körperflüssigkeiten in hoher Qualität zu sammeln, zu lagern und für die wissenschaftliche Forschung zur Verfügung zu stellen. Sie ist Teil des „Comprehensive Pneumology Centers München“ (CPC-M) und Mitglied im Deutschen Zentrum für Lungenforschung (DZL), einer vom Bundesministerium für Bildung und Forschung unterstützten Einrichtung, die sich die weitere Erforschung und die Entwicklung neuer Therapieverfahren von und für Lungenerkrankungen zum Ziel gemacht hat. Als Teil dieser Bemühungen sind in der Plattform Biobanking im DZL Biobanken an den verschiedenen Standorten, u.a. auch in Gauting, etabliert.
General Design
- Type
- Biobank
- Start/End data collection
- not available
- PID
- 21.12110/1.2402-7318-A420
- External identifiers
- bbmri-eric:ID:DE_ASK-Tx
Population
- Countries
- Germany
Contributors
Subpopulations
List of subpopulations for this resource
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Networks
Part of networks